Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Heller

Showing results (81-90 of 219) with videos related to

Pageof 22
Sort By:
Immunopharmacology|May 1, 1996
Influence of heparin, heparin plus aprotinin and hirudin on contact activation in a cardiopulmonary bypass modelH P Wendel, W Heller, M J Gallimore
Die Medizinische Welt|May 10, 1974
[Drug effects on the oxygen utilization and metabolic acidosis in shock following skull-brain injuries]J Hausdörfer, W Heller, P Oldenkott, et al.
Plos One|March 20, 2015
Step detection and activity recognition accuracy of seven physical activity monitorsFabio A Storm, Ben W Heller, Claudia Mazzà
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|January 1, 1973
[Single Sulmycin (gentamycin)-treatment in gonorrhea]D Hatschke, W Heller, P Strauss, et al.
Die Medizinische Welt|February 27, 1976
[Changes in lipid metabolism following acute experimental craniocerebral injury]J Hausdörfer, W Heller, H Junger, et al.
Agents and Actions. Supplements|January 1, 1992
Studies on components of the plasma kallikrein system as a risk factor in diabetics undergoing cardiopulmonary bypassW Heller, M J Gallimore, H E Hoffmeister
Die Medizinische Welt|January 30, 1981
[Examinations of rat brains following ischemic and intravenous heparin administration]L Schaaf, J Durst, H Wiethölter, et al.
Immunopharmacology|May 1, 1996
Heparin-coated devices and high-dose aprotinin optimally inhibit contact system activation in an in vitro cardiopulmonary bypass modelH P Wendel, W Heller, M J Gallimore
Acta Neurochirurgica|January 1, 1971
The enzyme-pathobiochemistry of intracranial processes. A contributionP Oldenkott, W Heller, H Blankenhorn, et al.
Planta|November 19, 2013
Enzymatic reduction of (+)-dihydroflavonols to flavan-3,4-cis-diols with flower extracts from Matthiola incana and its role in anthocyanin biosynthesisW Heller, G Forkmann, L Britsch, et al.
Pageof 22

Showing results (81-90 of 219) with videos related to

Sort By:
Pageof 22
Immunopharmacology|May 1, 1996
Influence of heparin, heparin plus aprotinin and hirudin on contact activation in a cardiopulmonary bypass modelH P Wendel, W Heller, M J Gallimore
Die Medizinische Welt|May 10, 1974
[Drug effects on the oxygen utilization and metabolic acidosis in shock following skull-brain injuries]J Hausdörfer, W Heller, P Oldenkott, et al.
Plos One|March 20, 2015
Step detection and activity recognition accuracy of seven physical activity monitorsFabio A Storm, Ben W Heller, Claudia Mazzà
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|January 1, 1973
[Single Sulmycin (gentamycin)-treatment in gonorrhea]D Hatschke, W Heller, P Strauss, et al.
Die Medizinische Welt|February 27, 1976
[Changes in lipid metabolism following acute experimental craniocerebral injury]J Hausdörfer, W Heller, H Junger, et al.
Agents and Actions. Supplements|January 1, 1992
Studies on components of the plasma kallikrein system as a risk factor in diabetics undergoing cardiopulmonary bypassW Heller, M J Gallimore, H E Hoffmeister
Die Medizinische Welt|January 30, 1981
[Examinations of rat brains following ischemic and intravenous heparin administration]L Schaaf, J Durst, H Wiethölter, et al.
Immunopharmacology|May 1, 1996
Heparin-coated devices and high-dose aprotinin optimally inhibit contact system activation in an in vitro cardiopulmonary bypass modelH P Wendel, W Heller, M J Gallimore
Acta Neurochirurgica|January 1, 1971
The enzyme-pathobiochemistry of intracranial processes. A contributionP Oldenkott, W Heller, H Blankenhorn, et al.
Planta|November 19, 2013
Enzymatic reduction of (+)-dihydroflavonols to flavan-3,4-cis-diols with flower extracts from Matthiola incana and its role in anthocyanin biosynthesisW Heller, G Forkmann, L Britsch, et al.
Pageof 22